MedPath

Evaluating the effect of Cinnamon on HbA1C in diabetic patients

Phase 2
Conditions
Diabetes mellitus.
Non-insulin-dependent diabetes mellitus
Registration Number
IRCT2015010713612N4
Lead Sponsor
Bone Research Center, Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

type 2 diabetes mellitus; Patients aged from 18 to 65 years old; HbA1c less than 8, blood pressure less than 140/90.
Exclusion criteria: diabetes type 1; Patients younger than 18 or older than 65 years; Having kidney, thyroid or liver disease simultaneously; HbA1c greater than 8; blood pressure over 140/90; Changing the dose or type of medication over the last six months; Pregnancy.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hemoglobin A1c. Timepoint: At baseline and three months after satrting treatment. Method of measurement: Chromatography.;Body Mass Index. Timepoint: At baseline and three months after starting treatment. Method of measurement: weight(kg)÷height(m)^2.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath